-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Fractyl Health, Raises Price Target to $40

Benzinga·11/13/2026 13:45:44
Listen to the news
Canaccord Genuity analyst Whitney Ijem maintains Fractyl Health (NASDAQ:GUTS) with a Buy and raises the price target from $39 to $40.